Tag: investment
-
Novartis Acquires Nuclear Meds Developer in $3.9B Deal
Drug maker Novartis is purchasing a company that develops therapies and diagnostics using radio isotopes for neuroendocrine and other cancers.
-
Multi-Drug Resistance Antibiotic Developer to Issue IPO
A three year-old company making new antibiotics to treat infections resistant to earlier antibiotics plans to raise some $75 million in its initial public stock offering.
-
Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal
Drug maker Eli Lilly and Company and biotechnology company CureVac AG agreed to develop a series of cancer immunotherapies based on CureVac’s messenger RNA technology.
-
Infographic – Europe’s High Value Tech Companies
Our friends at Statista this week collected the top European technology companies in market value, displayed in this chart.
-
Infographic – Google’s Largest Acquisitions
Our friends at Statista yesterday published this chart showing Google/Alphabet’s largest acquisitions over the years.
-
Neuro Disease Start-Up Gains $30M in Early Funds
A start-up enterprise developing treatments for several neurological diseases that the company says are triggered by a common destructive protein, is raising $30 million its first venture financing round.
-
3-D Organ Printing Company Gains Seed Funds
A start-up enterprise seeking to create replacement human tissue and organs with three-dimensional printing is raising $1.8 million in seed capital.
-
The Four Biggest Money Mistakes A Business Can Make
Many business owners make these mistakes and end up costing themselves the business.
-
Synthetic DNA Start-Up Raises $13M in Early Funds
A company producing synthesized DNA for medical and other biotechnology applications is raising €11 million ($US 13 million) in its first venture funding round.
-
Start-Up Lands $10M for Gene-Editing HIV Treatments
A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round.